These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16650359

  • 1. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients.
    Skoll A, St Louis P, Amiri N, Delisle MF, Lalji S.
    J Obstet Gynaecol Can; 2006 Mar; 28(3):206-213. PubMed ID: 16650359
    [Abstract] [Full Text] [Related]

  • 2. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, Melchor I, Burgos J.
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [Abstract] [Full Text] [Related]

  • 3. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM, Fox NS, Chasen ST.
    J Perinat Med; 2008 May; 36(3):202-5. PubMed ID: 18576928
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Vandenbussche FP, Woiski MD, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvank BW, van Eyck J, Franssen MT, Sollie KM, van der Post JA, Bossuyt PM, Opmeer BC, Kok M, Mol BW, van Baaren GJ.
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [Abstract] [Full Text] [Related]

  • 5. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC, Khalil A, Wing D, Schleussner E, Surbek D.
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [Abstract] [Full Text] [Related]

  • 6. Can the fetal fibronectin test be used by remote dwelling pregnant women to predict the onset of labour at term and delay transfer for birth in regional settings?
    Rumbold A, Kruske S, Boyle J, Weckert R, Putland S, Giles L, Barclay L, Kildea S.
    Rural Remote Health; 2013 Oct; 13(2):2126. PubMed ID: 23351083
    [Abstract] [Full Text] [Related]

  • 7. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation.
    Parker J, Bell R, Brennecke S.
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):257-61. PubMed ID: 8546638
    [Abstract] [Full Text] [Related]

  • 8. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY, Seto MTY, Lewis H, Cheung KW.
    BMC Pregnancy Childbirth; 2023 Apr 04; 23(1):225. PubMed ID: 37016314
    [Abstract] [Full Text] [Related]

  • 9. Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta.
    Chuck AW, Thanh NX, Chari RS, Wilson RD, Janes-Kelley S, Wesenberg JC.
    J Obstet Gynaecol Can; 2016 Jul 04; 38(7):659-666.e6. PubMed ID: 27591351
    [Abstract] [Full Text] [Related]

  • 10. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM, Sener T, Yildiz Z.
    Clin Exp Obstet Gynecol; 2008 Jul 04; 35(1):61-4. PubMed ID: 18390084
    [Abstract] [Full Text] [Related]

  • 11. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study.
    Levine LD, Downes KL, Romero JA, Pappas H, Elovitz MA.
    J Matern Fetal Neonatal Med; 2019 Nov 04; 32(22):3792-3800. PubMed ID: 29727248
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY, Lee JY, Kim HM, Kim MJ, Cha HH, Seong WJ.
    BMC Pregnancy Childbirth; 2019 Jul 11; 19(1):241. PubMed ID: 31296172
    [Abstract] [Full Text] [Related]

  • 13. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
    Benson JE, Landy HJ, Ghidini A, Drassinower D, Poggi SH.
    J Matern Fetal Neonatal Med; 2012 Nov 11; 25(11):2330-2. PubMed ID: 22694302
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients.
    Cooper S, Lange I, Wood S, Tang S, Miller L, Ross S.
    J Perinatol; 2012 Jun 11; 32(6):460-5. PubMed ID: 21997470
    [Abstract] [Full Text] [Related]

  • 15. [Preliminary results of fetal fibronectin testing in twin pregnancies].
    Markova I, Nikolov A, Markov P.
    Akush Ginekol (Sofiia); 2014 Jun 11; 53(6):4-8. PubMed ID: 25993735
    [Abstract] [Full Text] [Related]

  • 16. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F, Fortin S, Delvin E, Djemli A, Brunet S, Dubé J, Fraser WD.
    J Obstet Gynaecol Can; 2010 Apr 11; 32(4):307-12. PubMed ID: 20500936
    [Abstract] [Full Text] [Related]

  • 17. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
    Duhig KE, Chandiramani M, Seed PT, Briley AL, Kenyon AP, Shennan AH.
    BJOG; 2009 May 11; 116(6):799-803. PubMed ID: 19432568
    [Abstract] [Full Text] [Related]

  • 18. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J, Chedraui P, Hidalgo L, Medina M.
    J Matern Fetal Neonatal Med; 2009 Feb 11; 22(2):89-93. PubMed ID: 19085632
    [Abstract] [Full Text] [Related]

  • 19. Fetal fibronectin detection in preterm labor: evaluation of a prototype bedside dipstick technique and cervical assessment.
    Coleman MA, McCowan LM, Pattison NS, Mitchell M.
    Am J Obstet Gynecol; 1998 Dec 11; 179(6 Pt 1):1553-8. PubMed ID: 9855595
    [Abstract] [Full Text] [Related]

  • 20. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin.
    Riboni F, Vitulo A, Dell'avanzo M, Plebani M, Battagliarin G, Paternoster D.
    Arch Gynecol Obstet; 2011 Dec 11; 284(6):1325-9. PubMed ID: 21274721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.